In the general news, Trump and Sanders won Michigan, shocking Clinton. Meanwhile, leftist protestors repeatedly disrupted Trump rallies, becoming more violent. Lastly, Nancy Reagan died.
In healthcare business news, JNJ’s Ethicon unit acquired NeuWave for its tumor ablation device.
On the data front, Celldex (CLDX) shares sank when it stopped the pivotal trial for cancer drug Rintega. Also, Vericel’s (VCEL) stem cell therapy ixmyelocel-T worked in trials for ischemic dilated heart failure, sending shares up 100%.
From the FDA, Pfizer’s (PFE) Xalkori to treat ROS-1 positive NSCLC was approved one year after it won Breakthrough status.